Eltrombopag — Medica
Thrombocytopenia in a Patient Post-Allogeneic Transplantation
Initial criteria
- according to prescriber, patient has poor graft function
- platelet count < 50 x 10^9/L
- prescribed by or in consultation with a hematologist, oncologist, or stem cell transplant specialist physician
Reauthorization criteria
- according to prescriber, patient demonstrated a beneficial clinical response (e.g., increased platelet counts, maintenance of platelet counts, and/or decreased frequency of bleeding episodes)
Approval duration
initial: 3 months; reauth: 6 months